These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10715286)

  • 21. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A; Biron P; Philip I; Blay JY; Droz JP
    Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases.
    Papiani G; Einhorn LH
    Bone Marrow Transplant; 2007 Aug; 40(3):235-7. PubMed ID: 17563738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
    Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
    J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer.
    Bhatia S; Abonour R; Porcu P; Seshadri R; Nichols CR; Cornetta K; Einhorn LH
    J Clin Oncol; 2000 Oct; 18(19):3346-51. PubMed ID: 11013274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
    Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy without irradiation--a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study.
    Balmaceda C; Heller G; Rosenblum M; Diez B; Villablanca JG; Kellie S; Maher P; Vlamis V; Walker RW; Leibel S; Finlay JL
    J Clin Oncol; 1996 Nov; 14(11):2908-15. PubMed ID: 8918487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
    Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
    J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
    Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of patients with good-risk germ cell tumors treated with etoposide and cisplatin.
    Xiao H; Mazumdar M; Bajorin DF; Sarosdy M; Vlamis V; Spicer J; Ferrara J; Bosl GJ; Motzer RJ
    J Clin Oncol; 1997 Jul; 15(7):2553-8. PubMed ID: 9215824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
    Lorch A; Kollmannsberger C; Hartmann JT; Metzner B; Schmidt-Wolf IG; Berdel WE; Weissinger F; Schleicher J; Egerer G; Haas A; Schirren R; Beyer J; Bokemeyer C; Rick O;
    J Clin Oncol; 2007 Jul; 25(19):2778-84. PubMed ID: 17602082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
    Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
    Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
    Rick O; Bokemeyer C; Beyer J; Hartmann JT; Schwella N; Kingreen D; Neureither S; Metzner B; Casper J; Wandt H; Hartmann F; Schmoll HJ; Derigs G; Gerl A; Berdel WE; Kanz L; Siegert W
    J Clin Oncol; 2001 Jan; 19(1):81-8. PubMed ID: 11134198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study.
    Ferhatoglu F; Paksoy N; Khanmammadov N; Yildiz A; Ahmed MA; Gülbas Z; Basaran M
    Medicine (Baltimore); 2024 Feb; 103(8):e37213. PubMed ID: 38394499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.
    Faure-Conter C; Orbach D; Cropet C; Baranzelli MC; Martelli H; Thebaud E; Vérité C; Rome A; Fasola S; Corradini N; Rocourt N; Frappaz D; Kalfa N; Patte C
    Pediatr Blood Cancer; 2014 Feb; 61(2):253-9. PubMed ID: 23940114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors.
    Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M
    Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience.
    Saxman SB; Nichols CR; Einhorn LH
    J Clin Oncol; 1994 Jul; 12(7):1390-3. PubMed ID: 8021729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.
    Motzer RJ; Mazumdar M; Bosl GJ; Bajorin DF; Amsterdam A; Vlamis V
    J Clin Oncol; 1996 Apr; 14(4):1098-105. PubMed ID: 8648363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
    De Giorgi U; Rosti G; Papiani G; Marangolo M
    Haematologica; 2002 Jan; 87(1):95-104. PubMed ID: 11801470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
    Motzer RJ; Mazumdar M; Bajorin DF; Bosl GJ; Lyn P; Vlamis V
    J Clin Oncol; 1997 Jul; 15(7):2546-52. PubMed ID: 9215823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
    Lorch A; Neubauer A; Hackenthal M; Dieing A; Hartmann JT; Rick O; Bokemeyer C; Beyer J
    Ann Oncol; 2010 Apr; 21(4):820-825. PubMed ID: 19822531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.